Stockscreener 앱 받기
86.84
0.44%
0.38
시간 외 거래:
86.84
전일 마감가:
$86.46
열려 있는:
$86.56
하루 거래량:
763.35K
Relative Volume:
0.61
시가총액:
$10.24B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
36.95
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
-1.58%
1개월 성능:
-13.73%
6개월 성능:
-26.94%
1년 성능:
-27.10%
1일 변동 폭
$85.67
$87.41
1주일 범위
$85.12
$89.78
52주 변동 폭
$85.12
$129.50
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
86.84 | 9.97B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
What makes Revvity Inc. stock price move sharplyFast Return with Technical Confirmation - thegnnews.com
Stock Analysis | Revvity OutlookMixed Signals Amid Sector Developments - AInvest
Revvity’s pHSense Enables High Throughput Internalization - Precedence Research
Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN
Revvity's (NYSE:RVTY) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Revvity launches innovative reagent technology to accelerate therapeutics development - BioSpectrum Asia
Revvity Launches Innovative Reagent Technology to Accelerate Dev - GuruFocus
Revvity Unveils PHSense Reagents To Advance Internalization Studies In Drug Discovery - 富途牛牛
Revolutionary Lab Technology by Revvity Promises to Cut Drug Development Time in Half - Stock Titan
Revvity 2025 Q2 Earnings Sustained Profitability Amid Slight Earnings Decline - AInvest
3 Healthcare Stocks to Avoid: GE HealthCare, Universal Health Services, and Revvity - AInvest
Earnings Preview: What to Expect From Revvity's Report - MSN
What's Going On With Revvity Stock Today? - 富途牛牛
Revvity Inc.’s Price Action Aligns with Quant SignalsBreakout Confirmation With Entry Tracker Enabled - metal.it
Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - 富途牛牛
Is it the right time to buy Revvity Inc. stockTurn volatility into profit opportunities - Jammu Links News
What are Revvity Inc. company’s key revenue driversOutstanding capital appreciation - Jammu Links News
What are the technical indicators suggesting about Revvity Inc.Consistent high-performance stocks - Jammu Links News
How does Revvity Inc. generate profit in a changing economyConsistently superior profits - Jammu Links News
What is the dividend policy of Revvity Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News
Revvity, Inc. Stock (RVTY) Opinions on Quarterly Earnings Report - Quiver Quantitative
What is the risk reward ratio of investing in Revvity Inc. stockUnlock steady growth with low-risk stocks - Jammu Links News
Is Revvity Inc. a good long term investmentExceptional trading results - Jammu Links News
Does Revvity Inc. stock perform well during market downturnsInvest confidently with real-time updates - Jammu Links News
How many analysts rate Revvity Inc. as a “Buy”Achieve consistent double-digit growth - Jammu Links News
Why is Revvity Inc. stock attracting strong analyst attentionFree Capital Efficiency Planning - Jammu Links News
When is Revvity Inc. stock expected to show significant growthGain the edge with real-time market data - Jammu Links News
What institutional investors are buying Revvity Inc. stockHigh-yield trading alerts - Jammu Links News
How strong is Revvity Inc. company’s balance sheetFree Technical Analysis Support - Jammu Links News
Is Revvity Inc. a growth stock or a value stockBest Dividend Forecasts To Watch Now - Jammu Links News
Revvity stock hits 52-week low at 87.63 USD - Investing.com Australia
Revvity stock hits 52-week low at 87.63 USD By Investing.com - Investing.com Canada
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - Stocktwits
Revvity price target lowered to $110 from $120 at Stifel - Yahoo Finance
A Quick Look at Today's Ratings for Revvity(RVTY.US), With a Forecast Between $102 to $115 - 富途牛牛
Revvity Repeat Insider Selling Not A Positive Indicator - 富途牛牛
Revvity, Inc. Earnings Call: Mixed Sentiment and Strategic Moves - The Globe and Mail
Revvity Inc. Earnings Report Breakdown: What Investors Should KnowMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures - Investing.com Nigeria
Stifel lowers Revvity stock price target to $110 on China ImmunoDx pressures By Investing.com - Investing.com South Africa
Raymond James lowers Revvity stock price target to $115 on China headwinds - Investing.com Nigeria
Revvity price target lowered to $115 from $120 at Raymond James - TipRanks
Revvity, Inc. (NYSE:RVTY) Q2 2025 Earnings Call Transcript - Insider Monkey
Revvity stock price target lowered to $115 by Bernstein on China headwinds - Investing.com
Revvity's Struggles in a Post-Pandemic Market: Is a Dividend Cut Looming? - AInvest
Revvity: Not A Healthy Diagnosis For This Life Science Business (NYSE:RVTY) - Seeking Alpha
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... - Yahoo Finance
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... By GuruFocus - Investing.com Canada
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):